---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-000427"
form_type: "8-K"
ticker: "PMN"
cik: "0001374339"
company_name: "ProMIS Neurosciences Inc."
filed_at: "2025-01-27T23:59:59+00:00"
generated_at: "2026-05-27T09:07:59.567690+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ProMIS Neurosciences releases updated corporate presentation; no material new data disclosed

## Summary
- Presentation dated January 27, 2025, posted to company website.
- Targets neurodegenerative disease with focus on misfolded proteins.
- No specific financial results, guidance, or pipeline milestones disclosed.
- Filed as Regulation FD disclosure; not incorporated by reference.

## SEC filing metadata
- accession: 0001558370-25-000427
- form_type: 8-K
- ticker: PMN
- cik: 0001374339
- company_name: ProMIS Neurosciences Inc.
- filed_at: 2025-01-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1374339/000155837025000427/0001558370-25-000427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1374339/000155837025000427/pmn-20250127x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-000427
- JSON: https://secwatch.observer/filing/0001558370-25-000427.json
- Plain text: https://secwatch.observer/filing/0001558370-25-000427.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.